Aurealis Pharma is a biopharmaceutical company developing a technology enabling “three-in-one” combination therapy in one single product.
Safe lactic acid bacteria are injected into the diseased tissue acting locally as millions of bioreactors producing three selected therapeutic drugs.

Cooperation possibilities

It is our aim to optimize our strategic options throughout the lifetime of the company, including an early trade sale of the platform, early partnering or out-licensing with pharma/biotech for joint development or a potential IPO, to occur ideally when the company will reach clinical status.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    1-9
Key business